Hospitalogy November 12, 2024
Blake Madden

Drug Distributors continue Vertical Integration Strategy as Cencora, Cardinal make Big Bets

Deals among PE-backed physician practice management players and strategic buyers (drug distributors in this case) are heating up.

On November 6, Cencora bought Retina Consultants of America (RCA) for $4.6B (an 85% stake and $500M in incentive payments).

  • RCA serves 300+ retina specialists in 23 states and sees 2 million patient visits annually.
  • Interestingly RCA specializes in clinical trials in research, which Cencora is sure to have an invested (literally) interest in.
  • Through eventually owning both OneOncology and RCA, Cencora will look to build out a more integrated management services organization (an MSO, as our industry so fondly loves its acronym) to house its services subsidiary.
...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Health System / Hospital, Insurance, Medicare, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Physician, Provider, Trends
NVentures Invests in Genesis Therapeutics’ AI Platform for Drug Development
3 Ways The New Administration Could Speed The Path To New Medicines
What retail pharmacy closures spell for healthcare
Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court
Dear President-Elect Trump: To Reach The Next Cure, Fix These Policies

Share This Article